Asker’s $888.1 million IPO on the Nasdaq Stockholm is the largest healthcare IPO of the year so far, according to the DNB and Back Bay report. That could bode well for commercial-stage Caris.

As a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical ...

U.S. stock futures are edging lower as investors digest President Donald Trump's comments on Iran, while shares of Accenture ...

IPO Calendar. M&A Calendar. SPAC Calendar. Stock Split Calendar. Trade Ideas. ... The stock price for Passage Bio (NASDAQ: PASG) is $0.3232 last updated June 27, 2025 at 7:01 PM EDT. Q.

A high-level overview of Passage Bio, Inc. (PASG) stock. View ... IPO Update: Passage Bio Finalizes $126 Million IPO Plan ... Is Passage Bio, Inc. listed on the NASDAQ or NYSE?

Chime Financial is expected to debut on the Nasdaq today. The fintech company’s initial public offering (IPO) is one of the most anticipated of 2025, and investors and market watchers will be ...

A strong and vibrant IPO market in the Nasdaq in 2025 is undoubtedly creating major opportunities for both companies and investors:. Robust Momentum and Activity in the Market; Nasdaq is ...

TELA Bio, Inc., a medical technology company specializing in soft-tissue reconstruction solutions, has announced the appointment of Jeffrey Blizard as President, effective immediately. Blizard ...

MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction ...

Exchange operator Nasdaq is holding active talks with companies considering stock market debuts, CEO Adena Friedman said on Thursday, underscoring the U.S. economy's resilience despite tariff ...

Get the detailed quarterly/annual income statement for Passage Bio, Inc. (PASG). Find out the revenue, expenses and profit or loss over the last fiscal year.